SG11202001576SA - Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing same - Google Patents
Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing sameInfo
- Publication number
- SG11202001576SA SG11202001576SA SG11202001576SA SG11202001576SA SG11202001576SA SG 11202001576S A SG11202001576S A SG 11202001576SA SG 11202001576S A SG11202001576S A SG 11202001576SA SG 11202001576S A SG11202001576S A SG 11202001576SA SG 11202001576S A SG11202001576S A SG 11202001576SA
- Authority
- SG
- Singapore
- Prior art keywords
- composition containing
- binding affinity
- cosmetic composition
- cell receptor
- receptor binding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170107511 | 2017-08-24 | ||
KR1020180006114A KR101917854B1 (en) | 2017-08-24 | 2018-01-17 | Peptides having capacity of binding to cell receptor and cosmetic composition comprising the same |
PCT/KR2018/000916 WO2019039676A1 (en) | 2017-08-24 | 2018-01-19 | Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing same |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202001576SA true SG11202001576SA (en) | 2020-03-30 |
Family
ID=64398005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202001576SA SG11202001576SA (en) | 2017-08-24 | 2018-01-19 | Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing same |
Country Status (12)
Country | Link |
---|---|
US (1) | US11242366B2 (en) |
JP (3) | JP6946565B2 (en) |
KR (3) | KR101917854B1 (en) |
CN (3) | CN110167953B (en) |
AU (2) | AU2018320089B2 (en) |
CA (1) | CA3072042C (en) |
MX (1) | MX2020001910A (en) |
MY (1) | MY191670A (en) |
PH (1) | PH12020500313A1 (en) |
RU (1) | RU2743036C1 (en) |
SG (1) | SG11202001576SA (en) |
WO (1) | WO2019039676A1 (en) |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU85952A1 (en) * | 1985-06-14 | 1987-01-13 | Oreal | NOVEL HEMIACETAL COMPOUNDS AND THEIR APPLICATIONS |
WO2000003245A1 (en) * | 1998-05-28 | 2000-01-20 | Chugai Pharmaceutical Company Limited | Peptide ligands for the human fibroblast growth factor (fgf) receptor |
US6767896B1 (en) * | 1999-01-29 | 2004-07-27 | Cognetix, Inc. | Conotoxin peptides |
AU2008201780B2 (en) * | 1999-09-07 | 2012-05-17 | Amgen Inc. | Fibroblast growth factor-like polypeptides |
AU2004251616A1 (en) | 2003-06-19 | 2005-01-06 | Eli Lilly And Company | Melanocortin receptor 4(MC4) agonists and their uses |
KR101051557B1 (en) | 2004-12-23 | 2011-07-22 | (주)아모레퍼시픽 | Method for producing polymer microcapsules in which vitamin VII is collected and cosmetic composition containing same |
FR2885803B1 (en) * | 2005-05-17 | 2012-08-10 | Oreal | COSMETIC USE OF VITAMIN K AS A NATURAL ENLUMINATOR OF SKIN OR LIP |
WO2008045252A2 (en) * | 2006-10-04 | 2008-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | Engineered integrin binding peptides |
WO2008142165A1 (en) * | 2007-05-24 | 2008-11-27 | Ablynx N.V. | Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
CN110577945A (en) * | 2007-10-03 | 2019-12-17 | 维莱尼姆公司 | xylanases, nucleic acids encoding them, and methods for making and using them |
US9012723B2 (en) | 2009-01-16 | 2015-04-21 | Monsanto Technology Llc | Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits |
JP2010220611A (en) * | 2009-02-27 | 2010-10-07 | Sanyo Chem Ind Ltd | Medium for subculture and method for producing cell |
KR101198918B1 (en) * | 2009-09-01 | 2012-11-07 | (주)케어젠 | WNT10 Derived Peptides and Uses Thereof |
KR101130550B1 (en) * | 2009-10-29 | 2012-03-23 | 고려대학교 산학협력단 | Cell Penetrating Peptide Modified Nanoliposome and Anti-Atopic Composition Comprising the Same |
UA109888C2 (en) * | 2009-12-07 | 2015-10-26 | ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES | |
US9029509B2 (en) * | 2010-02-12 | 2015-05-12 | The Regents Of The University Of California | Antibodies and pharmaceutical compositions thereof which bind urokinase-type plasminogen activator receptor (uPAR) |
JP5860268B2 (en) * | 2010-11-04 | 2016-02-16 | 三洋化成工業株式会社 | Chemically modified cell adhesion polypeptide |
JP5757563B2 (en) * | 2011-05-13 | 2015-07-29 | 株式会社ツツミプランニング | Cosmetics |
WO2012158960A2 (en) | 2011-05-17 | 2012-11-22 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | Melanocortin 1 receptor ligands and methods of use |
KR101285259B1 (en) * | 2011-08-04 | 2013-07-11 | (주)케어젠 | WNT family Derived Peptides and Uses Thereof |
CN102296101B (en) | 2011-09-08 | 2013-06-05 | 浙江大学 | Method for preparing micro capsulate embedded antihypertensive peptide |
US20130202740A1 (en) * | 2012-02-08 | 2013-08-08 | Pepsico, Inc. | Acidic Aqueous Product Comprising Oil-Containing Microcapsules and Method for the Manufacture Thereof |
EP3057991B8 (en) * | 2013-10-15 | 2019-09-04 | The Scripps Research Institute | Chimeric antigen receptor t cell switches and uses thereof |
EP2875806A1 (en) * | 2013-11-20 | 2015-05-27 | Infinitec Activos, S.L. | Targeted capsules for the delivery of whitening agents in the skin |
US10175242B2 (en) * | 2014-02-28 | 2019-01-08 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Personalized myeloma detection |
WO2016171107A1 (en) * | 2015-04-20 | 2016-10-27 | 第一三共株式会社 | Detection of fgfr2 |
WO2017004561A1 (en) * | 2015-07-01 | 2017-01-05 | Alk-Abelló A/S | Peptide combinations and uses thereof for treating grass allergy |
RU2750675C1 (en) * | 2015-10-02 | 2021-07-01 | Симфоген А/С | Antibodies to pd-1 and compositions |
CN105294851B (en) * | 2015-12-07 | 2019-02-12 | 中国科学院长春应用化学研究所 | With the basic fibroblast growth factor and its encoding gene of chitin specific bond, preparation method and application |
EP3448875A4 (en) * | 2016-04-29 | 2020-04-08 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
-
2018
- 2018-01-17 KR KR1020180006114A patent/KR101917854B1/en active IP Right Grant
- 2018-01-19 MX MX2020001910A patent/MX2020001910A/en unknown
- 2018-01-19 AU AU2018320089A patent/AU2018320089B2/en active Active
- 2018-01-19 WO PCT/KR2018/000916 patent/WO2019039676A1/en active Application Filing
- 2018-01-19 MY MYPI2020000692A patent/MY191670A/en unknown
- 2018-01-19 US US16/636,458 patent/US11242366B2/en active Active
- 2018-01-19 JP JP2020530295A patent/JP6946565B2/en active Active
- 2018-01-19 SG SG11202001576SA patent/SG11202001576SA/en unknown
- 2018-01-19 RU RU2020111634A patent/RU2743036C1/en active
- 2018-01-19 CN CN201880001245.2A patent/CN110167953B/en active Active
- 2018-01-19 CN CN202211526860.XA patent/CN115850369A/en active Pending
- 2018-01-19 CN CN202211526859.7A patent/CN115925787A/en active Pending
- 2018-01-19 CA CA3072042A patent/CA3072042C/en active Active
- 2018-06-20 KR KR1020180070677A patent/KR102026221B1/en active IP Right Grant
- 2018-06-20 KR KR1020180070676A patent/KR102026220B1/en active IP Right Grant
-
2020
- 2020-02-11 PH PH12020500313A patent/PH12020500313A1/en unknown
-
2021
- 2021-05-25 JP JP2021087399A patent/JP7129141B2/en active Active
- 2021-05-25 JP JP2021087377A patent/JP7129140B2/en active Active
- 2021-10-01 AU AU2021240300A patent/AU2021240300B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA3072042C (en) | 2023-07-04 |
MX2020001910A (en) | 2020-07-13 |
US20200190143A1 (en) | 2020-06-18 |
CN110167953A (en) | 2019-08-23 |
JP2020530860A (en) | 2020-10-29 |
CN110167953B (en) | 2023-01-10 |
AU2018320089B2 (en) | 2021-07-29 |
PH12020500313A1 (en) | 2020-11-09 |
KR20190022306A (en) | 2019-03-06 |
JP7129141B2 (en) | 2022-09-01 |
AU2021240300B2 (en) | 2023-03-09 |
WO2019039676A1 (en) | 2019-02-28 |
AU2018320089A1 (en) | 2020-02-27 |
KR101917854B1 (en) | 2018-11-12 |
KR102026221B1 (en) | 2019-09-27 |
JP2021130684A (en) | 2021-09-09 |
JP2021130686A (en) | 2021-09-09 |
US11242366B2 (en) | 2022-02-08 |
KR20190022305A (en) | 2019-03-06 |
JP7129140B2 (en) | 2022-09-01 |
AU2021240300A1 (en) | 2021-10-28 |
CA3072042A1 (en) | 2019-02-28 |
JP6946565B2 (en) | 2021-10-06 |
MY191670A (en) | 2022-07-06 |
KR102026220B1 (en) | 2019-09-27 |
CN115925787A (en) | 2023-04-07 |
RU2743036C1 (en) | 2021-02-12 |
CN115850369A (en) | 2023-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271696A (en) | Agonist antibodies that bind human cd137 and uses thereof | |
IL271835B1 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
EP3607957A4 (en) | Pharmaceutical composition and cosmetic composition | |
EP3305802A4 (en) | Novel peptide and composition containing the same | |
GB201621818D0 (en) | Cosmetic composition and use thereof | |
EP3705121A4 (en) | Emopamil binding protein binding agent and use thereof | |
HK1259228A1 (en) | Two-phase cosmetic composition and use thereof for topical application | |
PL3639845T3 (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
EP3725799A4 (en) | Peptide bound to pl-l1 and use thereof | |
IL275593B (en) | Composition comprising probiotics and polypeptide having binding affinity for ige and use thereof | |
EP3426680A4 (en) | Activin type 2 receptor binding proteins and uses thereof | |
EP3459521A4 (en) | Emulsified composition and cosmetic using same | |
EP3449899A4 (en) | COMPOSITION FOR COSMETICS AND COSMETICs COMPRISING SAME | |
GB2587700B (en) | Solid hair cosmetic composition | |
EP3287121A4 (en) | Cosmetic base material and cosmetic containing said cosmetic base material | |
EP3735961A4 (en) | Cosmetic powder composite and cosmetic composition containing same | |
EP3733685A4 (en) | Peptides binding to cd44v6 and use thereof | |
SG11202001576SA (en) | Microcapsule including peptide having cell receptor binding affinity and cosmetic composition containing same | |
IL273202B1 (en) | Binding proteins to the human thrombin receptor, par4 | |
GB2587884B (en) | Solid hair cosmetic composition | |
GB2587885B (en) | Solid hair cosmetic composition | |
ZA202100166B (en) | Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof | |
SG11202001813UA (en) | Polypeptide and antibody bound to polypeptide | |
EP3474866A4 (en) | Cells expressing parathyroid hormone 1 receptor and uses thereof | |
EP3269349A4 (en) | Topically applied cosmetic reductive composition containing keratin and sulphur |